BeOne Medicines
A Study Start-Up Specialist at BeOne supports the initiation and activation of oncology clinical trials within the company's clinical operations function. The role operates within a global biotech environment, ensuring study activities align with regulatory and company standards while contributing to process improvements and cross-functional collaboration.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines is a global oncology company building the world's leading cancer medicine enterprise through an integrated model of discovery, development, and delivery. The company advances a broad pipeline of transformative therapies across hematology and solid tumors, driven by scientific excellence and speed. BeOne is committed to reaching more patients worldwide with innovative cancer treatments, including its marketed products and clinical-stage programs.
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
4 hours ago
Assessing BeOne Medicines (ONC) Valuation After Profit Turnaround And Optimistic 2026 Guidance
1 day ago
Capital International Investors Boosts Stake in BeOne Medicines Ltd. - Sponsored ADR $ONC
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
BeOne Medicines didn’t post a salary, so this is our estimate from similar listings.
BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside
1 week ago